{"title":"Discovery of drug targets for heart failure with preserved and reduced ejection fraction","authors":"Scott C. Ritchie","doi":"10.1038/s44161-024-00605-x","DOIUrl":null,"url":null,"abstract":"Drug targets that are supported by human genetics are more likely to lead to approved therapies. Research now identifies several promising drug targets and therapeutic repurposing opportunities for heart failure and its clinical sub-types.","PeriodicalId":74245,"journal":{"name":"Nature cardiovascular research","volume":"4 3","pages":"254-255"},"PeriodicalIF":10.8000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature cardiovascular research","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44161-024-00605-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Drug targets that are supported by human genetics are more likely to lead to approved therapies. Research now identifies several promising drug targets and therapeutic repurposing opportunities for heart failure and its clinical sub-types.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
